Literature DB >> 2556199

Delta-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones.

A F Sullivan1, A H Dickenson, B P Roques.   

Abstract

1. The effects of a selective delta-opioid agonist Tyr-D-Ser(Otbu)-Gly-Phe-Leu-Thr (DSTBULET) were examined on the C- and A beta-evoked responses of convergent dorsal horn neurones in the halothane anaesthetized, intact rat. 2. Intrathecal DSTBULET produced selective dose-dependent inhibitions of electrically-evoked C fibre responses of both superficial and deep neurones. A near-complete inhibition of 83 +/- 5% followed 100 micrograms of DSTBULET and the ED50 was 9 micrograms (13.5 nmol). Inhibitions were antagonised by intrathecal naloxone and ICI 174,864 but were not antagonised by pretreatment with intrathecal beta-funaltrexamine at a dose that blocked mu-opioid effects. By contrast, DSTBULET produced excitations of electrically-evoked responses of cells recorded in a zone intermediate between the superficial and deep neurones. 3. DSTBULET (50 micrograms) was also tested on the more prolonged noxious neuronal response produced by subcutaneous formalin (5%, 50 microliters) into the receptive field. DSTBULET profoundly inhibited the response to formalin. Pretreatment with ICI 174,864 before DSTBULET antagonised the effects of the delta-agonist on the formalin response. 4. The full peptidase inhibitor kelatorphan, known to protect endogenous enkephalins, was also tested on the formalin response. The intrathecal administration of 50 micrograms kelatorphan has previously been shown to inhibit electrically-evoked C fibre resonses of dorsal horn neurones and to be antagonised by ICI 174,864. The same dose of kelatorphan inhibited the formalin response in the present study. 5. From this study it appears that the delta-opioid agonist DSTBULET can produce profound inhibitions of the responses of convergent neurones to nociceptive afferent inputs. Furthermore, activation of delta-opioid receptors either by DSTBULET, or by protection of endogenous enkephalins with kelatorphan, can inhibit a more prolonged chemically-evoked nociceptive input onto these dorsal horn neurones.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556199      PMCID: PMC1854772          DOI: 10.1111/j.1476-5381.1989.tb14636.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  65 in total

1.  In vivo evidence for spinal delta-opiate receptor operated antinociception.

Authors:  R E Rodriguez; G Leighton; R G Hill; J Hughes
Journal:  Neuropeptides       Date:  1986-10       Impact factor: 3.286

Review 2.  Peripheral and spinal mechanisms of nociception.

Authors:  J M Besson; A Chaouch
Journal:  Physiol Rev       Date:  1987-01       Impact factor: 37.312

3.  Evidence that endogenous enkephalins produce delta-opiate receptor mediated neuronal inhibitions in rat dorsal horn.

Authors:  A H Dickenson; A Sullivan; C Feeney; M C Fournie-Zaluski; B P Roques
Journal:  Neurosci Lett       Date:  1986-12-12       Impact factor: 3.046

4.  Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.

Authors:  R D Russell; J B Leslie; Y F Su; W D Watkins; K J Chang
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

5.  Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cord.

Authors:  A H Dickenson; A F Sullivan; M C Fournie-Zaluski; B P Roques
Journal:  Brain Res       Date:  1987-04-07       Impact factor: 3.252

6.  Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands.

Authors:  R Quirion; J M Zajac; J L Morgat; B P Roques
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

7.  Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord.

Authors:  S Bourgoin; D Le Bars; F Artaud; A M Clot; R Bouboutou; M C Fournie-Zaluski; B P Roques; M Hamon; F Cesselin
Journal:  J Pharmacol Exp Ther       Date:  1986-07       Impact factor: 4.030

8.  Actions of opioids on primate spinothalamic tract neurons.

Authors:  W S Willcockson; J Kim; H K Shin; J M Chung; W D Willis
Journal:  J Neurosci       Date:  1986-09       Impact factor: 6.167

9.  Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the nociceptive flexion reflex in the rat.

Authors:  Z Wiesenfeld-Hallin; R Duranti
Journal:  Peptides       Date:  1987 Jan-Feb       Impact factor: 3.750

10.  Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord.

Authors:  A Mauborgne; O Lutz; J C Legrand; M Hamon; F Cesselin
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

View more
  2 in total

Review 1.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

Review 2.  Modulation of pain transmission by G-protein-coupled receptors.

Authors:  Hui-Lin Pan; Zi-Zhen Wu; Hong-Yi Zhou; Shao-Rui Chen; Hong-Mei Zhang; De-Pei Li
Journal:  Pharmacol Ther       Date:  2007-09-22       Impact factor: 12.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.